News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<IPO>AI and Biotech Startup Earendil Labs Mulls HK Listing to Raise USD500M: Wire
The biotech startup Earendil Labs, which focuses on AI drug development, is weighing a listing in Hong Kong, Bloomberg reported, citing people with the knowledge of the matter. The...
Reset
Send
The window will close in 5 seconds
<IPO>AI and Biotech Startup Earendil Labs Mulls HK Listing to Raise USD500M: Wire
Close
Recommend
22
Positive
18
Negative
15
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get 1 Intel/Selected Gold ETF share!

The biotech startup Earendil Labs, which focuses on AI drug development, is weighing a listing in Hong Kong, Bloomberg reported, citing people with the knowledge of the matter. The company is collaborating with CICC and Morgan Stanley on IPO matters, with a potential fundraising amount of up to USD500 million.

Yesterday (12th), WUXI BIO (02269.HK)  +1.420 (+4.259%)    Short selling $164.88M; Ratio 18.662%   announced that it had clinched a strategic cooperation agreement with Earendil Labs. WUXI BIO will provide integrated development and production services for several bispecific/ multi-specific antibodies and antibody-drug conjugates (ADC) in Earendil Labs' pipeline, which are used to treat autoimmune diseases, tumors, and other conditions.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-06-01 12:25.)

Related NewsWUXI BIO (02269.HK) Up 5% as Nomura Says Reiterated Full-year Revenue Growth Guidance and Buyback Signal Undervaluation

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.